期刊
JOURNAL OF CLINICAL ONCOLOGY
卷 33, 期 16, 页码 1745-+出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1200/JCO.2015.60.7879
关键词
-
类别
资金
- Astex Therapeutics (Inst)
- Champions Oncology (I)
- Aduro Biotech
The balance between tumor-promoting and tumor-suppressing immune responses and the difference between them ultimately determine whether a cancer escapes immune recognition mechanisms. Defining the complex relationships between the tumor itself, the tumor environment, and the immune system has been critical in facilitating the development of successful immunotherapies. This review explores the role of oncogenes in inducing cancer-associated inflammation, the local and systemic factors that lead to immune suppression, and immunotherapy approaches to overcome immune privilege. (C) 2015 by American Society of Clinical Oncology
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据